ReFacto

In the US, ReFacto (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.

US matches:

• Refacto recombinant


• Refacto

UK matches:

• ReFacto AF
• ReFacto AF (SPC)

Ingredient matches for ReFacto

Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Moroctocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of ReFacto in the following countries:

• Australia


• Austria


• Belgium


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hungary


• Iceland


• Italy


• Luxembourg


• Netherlands


• New Zealand


• Norway


• Portugal


• Slovakia


• Slovenia


• Spain


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.